Sana Biotechnology logo

Sana Biotechnology

sana.com

Sana Biotechnology develops engineered cell and gene therapies to repair, control, or replace cells in order to address the underlying causes of diseases such as diabetes, B-cell cancers, and B-cell related autoimmune disorders. Its mission is to create novel medicines that meaningfully improve patient outcomes and broaden access to transformative treatments.

Facts

Sectors
Biotechnology, Gene editing, Cell therapy, Biopharmaceuticals
Type
Corporation Seattle business license
Registered name
Sana Biotechnology Inc Seattle business license
Stage
Public
Members see funding amounts.
.

Is this your organization? Claim it

  • Leadership or executive-pay change Apr 24, 2026
  • Leadership or executive-pay change Feb 17, 2026
  • Leadership or executive-pay change Sep 5, 2025
  • Leadership or executive-pay change Aug 29, 2025
  • Signed a material agreement Aug 7, 2025
  • Leadership or executive-pay change Oct 8, 2024
  • Leadership or executive-pay change Sep 12, 2024
  • Leadership or executive-pay change Apr 18, 2024
  • Signed a material agreement Feb 8, 2024
  • Leadership or executive-pay change Apr 28, 2023
  • Leadership or executive-pay change Apr 10, 2023
  • Layoff announced: 15% of staff Nov 30, 2022 fiercebiotech.com Data: layoffs.fyi
  • Signed a material agreement Jun 1, 2022
  • Signed a material agreement Jan 11, 2022
  • Signed a material agreement Oct 19, 2021
  • Leadership or executive-pay change Sep 3, 2021
  • Signed a material agreement Jul 14, 2021
  • Leadership or executive-pay change Mar 2, 2021
  • Filed to go public Jan 13, 2021

People

  • Steve Harr Co-founder and President and Chief Executive Officer
  • Snehal Patel Executive, Executive Vice President and Chief Technical Officer

Online